EAM Investors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,222
| Closed | -$4.92M | – | 241 |
|
|
2025
Q1 | $4.92M | Buy |
+42,222
| New | +$4.92M | 0.85% | 10 |
|
|
2023
Q3 | – | Sell |
-18,102
| Closed | -$1.3M | – | 287 |
|
|
2023
Q2 | $1.3M | Buy |
+18,102
| New | +$1.3M | 0.24% | 191 |
|
|
2023
Q1 | – | Sell |
-14,458
| Closed | -$1.12M | – | 261 |
|
|
2022
Q4 | $1.12M | Sell |
14,458
-37,634
| -72% | -$2.9M | 0.23% | 207 |
|
|
2022
Q3 | $2.32M | Buy |
52,092
+932
| +2% | +$41.6K | 0.51% | 74 |
|
|
2022
Q2 | $1.96M | Buy |
+51,160
| New | +$1.96M | 0.48% | 72 |
|
|
2020
Q3 | – | Sell |
-29,293
| Closed | -$2.41M | – | 282 |
|
|
2020
Q2 | $2.41M | Sell |
29,293
-45,942
| -61% | -$3.78M | 0.53% | 51 |
|
|
2020
Q1 | $4.43M | Buy |
75,235
+3,679
| +5% | +$216K | 1.37% | 1 |
|
|
2019
Q4 | $7.4M | Sell |
71,556
-58,028
| -45% | -$6M | 1.63% | 1 |
|
|
2019
Q3 | $2.62M | Sell |
129,584
-18,887
| -13% | -$382K | 0.69% | 31 |
|
|
2019
Q2 | $3.82M | Sell |
148,471
-78,770
| -35% | -$2.03M | 0.94% | 5 |
|
|
2019
Q1 | $3.23M | Buy |
+227,241
| New | +$3.23M | 0.79% | 15 |
|